Visudyne wins European marketing approval - Approval should raise sales of light-activated drug

被引：0
作者：
Staples, S
机构：
来源：
GENETIC ENGINEERING NEWS | 2001年 / 21卷 / 08期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：38 / +
页数：1
相关论文
共 3 条
  • [1] Changing standards for drug approval: A longitudinal analysis of conditional marketing authorisation in the European Union
    Hoekman, Jarno
    Boon, Wouter
    SOCIAL SCIENCE & MEDICINE, 2019, 222 : 76 - 83
  • [2] Magnitude of clinical benefit in trials supporting US Food and Drug Administration (FDA) accelerated approval (AA) and European Medicines Agency (EMA) conditional marketing authorisation (CMA) and subsequent trials supporting conversion to full approval
    Borrell Puy, M.
    Molto Valiente, C.
    Vokinger, K.
    Hwang, T.
    Ocana Fernandez, A.
    Templeton, A. J.
    Seruga, B.
    Gich Saladich, I.
    Barnadas, A.
    Amir, E.
    Tibau, A.
    ANNALS OF ONCOLOGY, 2018, 29
  • [3] Single-Arm Clinical Trials as Pivotal Evidence for Cancer Drug Approval: A Retrospective Cohort Study of Centralized European Marketing Authorizations Between 2010 and 2019
    Tenhunen, Olli
    Lasch, Florian
    Schiel, Anja
    Turpeinen, Miia
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 108 (03) : 653 - 660
1